Barclays Bank Structured New Issues Preliminary Pricing Supplement (Cusip: 06741UFM1)

Barclays Bank Final Prospectus Cusip: 06740LEM3Did You Invest in Barclays Bank Structured New Issues Preliminary Pricing Supplement (Cusip: 06741UFM1), Linked to the Callable Leveraged Steepener Notes due July 31, 2034?

According to Barclays Bank Structured New Issues Preliminary Pricing Supplement (Cusip: 06741UFM1):

All payments on the notes, including the repayment of principal, are subject to the creditworthiness of Barclays Bank PLC. The notes are not, either directly or indirectly, an obligation of any third party, and any payment to be made on the notes, including the repayment of principal at maturity, depends on the ability of Barclays Bank PLC to satisfy its obligations as they come due.

Investors ought to be cautious with this type of investment. According to the Financial Industry Regulatory Authority (FINRA):

FINRA-Structured-Products


If you bought the structured product known as Barclays Bank Structured New Issues Preliminary Pricing Supplement (Cusip: 06741UFM1), Linked to the Callable Leveraged Steepener Notes due July 31, 2034, and it was sold to you as a safe, liquid, and/or conservative investment, and then you suffered losses, you may have a claim. Contact the attorneys at Sonn Law Group for free consultation.

Image credit: Tony Monblat via Flickr